To see all protocols that comply with the WHO Essential Medicine List 

This document is a quick and concise evidence-based summary to provide additional information, instruction, or guidance to complement a treatment protocol or clinical resource document. 

Clinical diagnostic criteria for Peutz-Jeghers syndrome (PJS)

A clinical diagnosis of PJS can be made when any ONE of the following is present in an individual: 

  1. Two or more histologically confirmed PJS-type hamartomatous polyps 
  2. Any number of Peutz-Jeghers polyps detected in an individual who has a family history of PJS in a close relative(s)
  3. Characteristic mucocutaneous pigmentation in an individual who has a family history of PJS in a close relative(s)
  4. Any number of Peutz-Jeghers polyps in an individual who also has characteristic mucocutaneous pigmentation.

The information contained in this document is based on the highest level of available evidence and consensus of the eviQ reference committee regarding their views of currently accepted approaches to care or treatment. Any clinician seeking to apply or consult this document is expected to use independent clinical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. While eviQ endeavours to link to reliable sources that provide accurate information, eviQ and the Cancer Institute NSW do not endorse or accept responsibility for the accuracy, currency, reliability or correctness of the content of linked external information sources. Use is subject to eviQ’s disclaimer available at www.eviQ.org.au

Send feedback for this page


First approved:
Last reviewed:
Review due:

The currency of this information is guaranteed only up until the date of printing, for any updates please check:

https://www.eviq.org.au/p/3184

29 Mar 2024